AIMNYSE American

AIM ImmunoTech Inc.

Alert me on AIM

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Oct 26 Buy Equels Thomas K Insider

1 week

Result due

1 month

Result in16 trading days

3 months

Result in58 trading days

6 months

Result in121 trading days

Oct 23 Buy Equels Thomas K Insider

1 week

−1.2%S&P −0.6%

1 month

Result in15 trading days

3 months

Result in57 trading days

6 months

Result in120 trading days

Sep 18 Buy Equels Thomas K Insider

1 week

−8.4%S&P +1.3%

1 month

−21.4%S&P +0.6%

3 months

Result in32 trading days

6 months

Result in95 trading days

Sep 17 Buy Equels Thomas K Insider

1 week

−6.4%S&P +0.9%

1 month

−22.6%S&P +0.3%

3 months

Result in31 trading days

6 months

Result in94 trading days

Sep 16 Buy Equels Thomas K Insider

1 week

−0.9%S&P +2.1%

1 month

−19.7%S&P +2.6%

3 months

Result in30 trading days

6 months

Result in93 trading days

Show all 6

Sep 16 Buy Equels Thomas K Insider

1 week

−0.9%S&P +2.1%

1 month

−19.7%S&P +2.6%

3 months

Result in30 trading days

6 months

Result in93 trading days

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for AIM

13 held · newest 513 held · newest 2

Loading the filings.

See all 13 filings for AIM

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.